Surrozen, Inc. Common (SRZN) is a publicly traded Healthcare sector company. As of May 21, 2026, SRZN trades at $27.16 with a market cap of $318.59M and a P/E ratio of -0.64. SRZN moved +4.50% today. Year to date, SRZN is +41.62%; over the trailing twelve months it is +219.37%. Its 52-week range spans $5.90 to $35.00. Analyst consensus is strong buy with an average price target of $42.50. Rallies surfaces SRZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SRZN include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Surrozen, Inc. Common.
| Metric | Value |
|---|---|
| Price | $27.16 |
| Market Cap | $318.59M |
| P/E Ratio | -0.64 |
| EPS | $-41.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.00 |
| 52-Week Low | $5.90 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $7.49M |
| Net Income | $-342.56M |
| Gross Margin | 0.00% |
5 analysts cover SRZN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.50.